The synthesis of this study provided emerging evidence that proteins such as Fetuin-A, Fetuin-B, ANGPTL8, RBP4, LECT2, and FGF21 might become potential biomarkers or modulators in NAFLD pathophysiology. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.